To assess cytotoxic activity of cytokine-treated NK cells, we co-cultured IL-2/IL-15-treated NK cells (E) and green fluorescent protein (GFP)-labeled GBM tumor cells (T) at different ratios. The gene discussed is IL15; the disease is glioblastoma.